Electrical Stimulation treating knee osteoarthritis for pain, function and strength

Not Applicable

• Conditions: Osteoarthritis of the knee; Musculoskeletal Diseases; Arthrosis

• Registration Number: ISRCTN12112819
• Lead Sponsor: Actegy Ltd

Brief Summary

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36008074/ (added 26/08/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-05-01
• Last Update Posted: 5 September 2022
• Study Completion: 2022-09-30

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 193

Inclusion Criteria

1. OA diagnosed clinically in accordance with NICE guidance.
2. Aged 45-85 years.

Exclusion Criteria

1. Fitted with an electronic implant such as a pacemaker or defibrillator.
2. Pregnant.
3. Existing or undergoing treatment for DVT.
4. Significantly impaired cognitive ability.
5. Inflammatory arthritis.
6. Dermatological conditions affecting the feet or legs.
7. Neurological disorder affecting the feet or legs.
8. Significant osteoarthritis of the hip, ankle or foot.
9. Current or recent knee surgery, trauma or injury (last 3 months).
10. Previous corticosteroid or hyaluronic acid injections (last 6 months).
11. BMI over 40.
12. Use of transcutaneous electrical stimulation.
13. Use of neuromuscular electrical stimulation device.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> Current primary outcome measure as of 13/05/2022:<br> The pain domain of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) questionnaire. The primary end point of the trial is week 8.<br><br> Previous primary outcome measure:<br> Osteoarthritis is measured using The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) at week 1 and week 8.<br>